Precision-targeted liposomes curb triple-negative breast cancer, metastases in mice
(Boston Children's Hospital) A novel precision medicine strategy described in Science Advances offers an intriguing ray of hope for triple-negative breast cancer. The proof-of-concept study shows that dually-targeted, antibody-guided nanoparticles, loaded with an existing chemotherapy drug, markedly improved tumor targeting, decreased tumor and metastatic growth and dramatically improved survival in a mouse model -- with no observable side effects.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Children | Hospitals | Nanotechnology | Science | Study